SRP187952 PRJNA526210 GSE128051 SHP2 Blockade Sensitizes Metastatic Triple Negative Breast Cancer to PI3K Inhibition Next Generation Sequencing was applied to investigate the effects of PI3K inhibition and/or SHP2 inhibition on the mouse mammary carcinoma 4T1. Overall design: RNA-Seq in 4 different treatment conditions to investigate PI3K/SHP2 signalling role in primary tumors. GSE128051 pubmed 37294349